Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives

TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Algernon Receives First Ethics Approval for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia

VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Tesla (TSLA) Compared To A Penny Stock Pump: Analyst

How Could Tesla Be A Penny Stock?! Elon Musk has been called…

Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Algernon Presents “The Science of Ifenprodil” on a Special BioPub Webcast Hosted by Dr. KSS, MD, PhD

ANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea

VANCOUVER, British Columbia, April 23, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

VANCOUVER, British Columbia, April 22, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…